Xue Song

2.0k citations
77 papers · 1.6k indexed · h-index 23

Xue Song

74 papers receiving 1.5k citations

Peers

Xue Song
Comparison fields: 5 of 128
  • Hematology 224
  • Internal Medicine 75
  • Family Practice 43
  • Rheumatology 198
  • Cardiology and Cardiovascular Medicine 231
Replace Reimer Rießen with:
Reimer Rießen Germany
Mark Silverberg United States
June M. McKoy United States
Aarón Sulkes Israel
Jules Lin United States
Roberto Coppola Italy
Pablo Lázaro Spain
Lova Sun United States
Anand B. Karnad United States
T. Urban France
Xue Song relative to Reimer Rießen Germany Reimer Rießen's profile →
Citations per field
00.5×1.5×2.4×
Reimer Rießen · 1×
Citations per year

Countries citing papers authored by Xue Song

Since Specialization
Citations

This map shows the geographic impact of Xue Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Song more than expected).

Fields of papers citing papers by Xue Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Song. The network helps show where Xue Song may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xue Song, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xue Song Line = papers co-authored together Xue Song links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20230
2 20227
3 20222
4 201920
5 20191
6 20184
7 20171
8 20171
9 201749
10 20174
11 20161
12 20165
13 201567
14 201563
15 201581
16
Costs of Treatment and Clinical Events for Secondary Hyperparathyroidism
20138
17 201223
18 201111
19 201031
20 200558

About Xue Song

Xue Song is a scholar working on Genetics, Hematology and Cardiology and Cardiovascular Medicine, having authored 77 papers that have together received 1.6k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Atrial Fibrillation Management and Outcomes (13 papers), Blood Pressure and Hypertension Studies (7 papers), Advanced biosensing and bioanalysis techniques (5 papers), Hemoglobinopathies and Related Disorders (5 papers), Cardiac Arrhythmias and Treatments (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Hematology (224 citations), Internal Medicine (75 citations) and Family Practice (43 citations). Xue Song has collaborated with scholars based in United States, Czechia and Switzerland. Frequent co-authors include Jiřı́ Homola, Maria Laura Ermini, Tomáš Špringer, Ze Cong, Kathleen Wilson, Ivana Víšová, Gilwan Kim, Hana Vaisocherová‐Lísalová, David M. Smith and Barbara H. Johnson. Their work appears in journals such as Current Medical Research and Opinion, Blood, Journal of Medical Economics, Value in Health and American Journal of Cardiovascular Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026